Publications for Jurate Savickiene
Co-author map based on ISI articles 2007-
Journal Articles
Rasa Merzvinskyte, Grazina Treigyte, Jurate Savickiene, Karl-Eric Magnusson and Ruta Navakauskiene
Effects of histone deacetylase inhibitors, sodium phenyl butyrate and vitamin B3, in combination with retinoic acid on granulocytic differentiation of human promyelocytic leukemia HL-60 cells
Annals of the New York Academy of Sciences, 2006, 1091, 356-367.
Web of Science® Times Cited: 7 |
Jurate Savickiene, Grazina Treigyte, Veronika Borutinskaite, Ruta Navakauskiene and Karl-Eric Magnusson
The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation
Annals of the New York Academy of Sciences, 2006, 1091, 368-384.
Web of Science® Times Cited: 13 |
Jurate Savickiene, Veronika-Viktorija Borutinskaite, Grazina Treigyte, Karl-Eric Magnusson and Ruta Navakauskiene
The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines
European Journal of Pharmacology, 2006, 549(1-3), 9-18.
Web of Science® Times Cited: 17 |
Jurate Savickiene, G Treigyte, A Pivoriunas, Ruta Navakauskiene and Karl-Eric Magnusson
Sp1 and NF-kappa B transcription factor activity in the regulation of the p21 and FasL promoters during promyelocytic leukemia cell monocytic differentiation and its associated apoptosis
Annals of the New York Academy of Sciences, 2004, 1030, 569-577.
Web of Science® Times Cited: 9 |
Ruta Navakauskiene, G Treigyte, Jurate Savickiene, A Gineitis and Karl-Eric Magnusson
Alterations in protein expression in HL-60 cells during etoposide-induced apoptosis modulated by the caspase inhibitor ZVAD.fmk
Annals of the New York Academy of Sciences, 2004, 1030, 393-402.
Web of Science® Times Cited: 5 |
Ph.D., Lic. Theses
